Why the study?
Does intensive lipid-lowering therapy improve regression of coronary lesions and reduce cardiovascular events in men with coronary artery disease and high levels of apolipoprotein B?
Does intensive lipid-lowering therapy improve regression of coronary lesions and reduce cardiovascular events in men with coronary artery disease and high levels of apolipoprotein B?
Intensive lipid-lowering therapy promotes regression of coronary lesions and reduces cardiovascular events in high-risk men with coronary artery disease and high apolipoprotein B.
Supports intensive lipid-lowering in high-apoB CAD men; confirms angiographic and clinical benefits in this RCT population.
In men with coronary artery disease who were at high risk for cardiovascular events, intensive lipid-lowering therapy reduced the frequency of progression of coronary lesions, increased the frequency of regression, and reduced the incidence of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Brown et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: